Monksdream
45 seconds ago
Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a clinical-stage biopharmaceutical company developing therapies for patients with cancer in need of new treatment options, and Decoy Therapeutics, Inc., a privately held preclinical biopharmaceutical company engineering the next generation of peptide co
getmoreshares
4 minutes ago
Outstanding Shares
4,703,166,972
01/13/2025
Restricted
513,619,938
01/13/2025
Unrestricted
4,189,547,034
01/13/2025
Held at DTC UNCHANGED
4,189,371,869
01/13/2025